{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:14:35Z","timestamp":1793420075080,"version":"4.5.0"},"reference-count":35,"publisher":"Bentham Science Publishers Ltd.","issue":"7","funder":[{"DOI":"10.13039\/501100017596","name":"Shaanxi Natural Science Basic research project","doi-asserted-by":"publisher","award":["2020JQ-525"],"award-info":[{"award-number":["2020JQ-525"]}],"id":[{"id":"10.13039\/501100017596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Research and Development Program of Science and Technology in Shaanxi Province","doi-asserted-by":"publisher","award":["2011K13-01-12"],"award-info":[{"award-number":["2011K13-01-12"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81172194"],"award-info":[{"award-number":["81172194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCDT"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n<jats:title>Background::<\/jats:title>\n<jats:p>A major challenge in cervical cancer radiotherapy is tailoring the radiation\ndoses efficiently to eliminate malignant cells and reduce the side effects in normal tissues. Oncolytic\nadenovirus drug H101 was recently tested and approved as a topical adjuvant treatment for several\nmalignancies.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This study aimed to evaluate the potential neoadjuvant radiotherapy benefits of H101 by\ntesting the inhibitory function of H101 in combination with radiation in different cervical cancer\ncells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Human cervical cancer cell lines C33a, SiHa, CaSki, and HeLa were treated with varying\nconcentrations of H101 alone or in combination with radiation (2 Gy or 4 Gy). Cell viability\nand apoptosis were measured at the indicated time intervals. HPV16 E6 and cellular p53 mRNA expression\nalteration was measured by qRT-PCR. In situ RNA scope was used to determine HPV E6\nstatus. P53 protein alterations were detected by Western blot.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> Cell viability and apoptosis assays revealed that the combination of a high dose of H101\n(MOI=1000, 10000) with radiation yielded a synergistic anticancer effect in all tested cervical cancer\ncell lines (P&lt;0.05), with the greatest effect achieved in HPV-negative C33a cells (P&lt;0.05).\nLow-HPV16-viral-load SiHa cells were more sensitive to the combination therapy than high-HPV16-\nviral-load CaSki cells (P&lt;0.05). The combined treatment reduced HPV16 E6 expression and\nincreased cellular P53 levels compared to those observed with radiation alone in SiHa and CaSki\ncells (P&lt;0.05).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions:<\/jats:title>\n<jats:p>Oncolytic adenovirus H101 effectively enhances the antitumor efficacy of radiation in\ncervical cancer cells and may serve as a novel combination therapy for cervical cancer.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1568009621666210308103541","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T04:08:39Z","timestamp":1615349319000},"page":"619-630","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Oncolytic Adenovirus H101 Synergizes with Radiation in Cervical Cancer Cells"],"prefix":"10.2174","volume":"21","author":[{"given":"Yixin","family":"Duan","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Institute of Molecular Radiobiology of Cancer, The First Affiliated Hospital of Xi'an Jiaotong University, Xian,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Institute of Molecular Radiobiology of Cancer, The First Affiliated Hospital of Xi'an Jiaotong University, Xian,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Institute of Molecular Radiobiology of Cancer, The First Affiliated Hospital of Xi'an Jiaotong University, Xian,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Institute of Molecular Radiobiology of Cancer, The First Affiliated Hospital of Xi'an Jiaotong University, Xian,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Institute of Molecular Radiobiology of Cancer, The First Affiliated Hospital of Xi'an Jiaotong University, Xian,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Institute of Molecular Radiobiology of Cancer, The First Affiliated Hospital of Xi'an Jiaotong University, Xian,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Institute of Molecular Radiobiology of Cancer, The First Affiliated Hospital of Xi'an Jiaotong University, Xian,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Institute of Molecular Radiobiology of Cancer, The First Affiliated Hospital of Xi'an Jiaotong University, Xian,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yili","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Institute of Molecular Radiobiology of Cancer, The First Affiliated Hospital of Xi'an Jiaotong University, Xian,China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"Bray F.","year":"2018","unstructured":"Bray F.; Ferlay J.; Soerjomataram I.; Siegel R.L.; Torre L.A.; Jemal A.; Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018,68(6),394-424","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.6004\/jnccn.2019.0001","volume":"17","author":"Koh W-J.","year":"2019","unstructured":"Koh W-J.; Abu-Rustum N.R.; Bean S.; Bradley K.; Campos S.M.; Cho K.R.; Chon H.S.; Chu C.; Clark R.; Cohn D.; Crispens M.A.; Damast S.; Dorigo O.; Eifel P.J.; Fisher C.M.; Frederick P.; Gaffney D.K.; Han E.; Huh W.K.; Lurain J.R.; Mariani A.; Mutch D.; Nagel C.; Nekhlyudov L.; Fader A.N.; Remmenga S.W.; Reynolds R.K.; Tillmanns T.; Ueda S.; Wyse E.; Yashar C.M.; McMillian N.R.; Scavone J.L.; Cervical cancer, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2019,17(1),64-84","journal-title":"J Natl Compr Canc Netw"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0140-6736(01)05965-7","volume":"358","author":"Green J.A.","year":"2001","unstructured":"Green J.A.; Kirwan J.M.; Tierney J.F.; Symonds P.; Fresco L.; Collingwood M.; Williams C.J.; Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001,358(9284),781-786","journal-title":"Lancet"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1002\/cncr.30667","volume":"123","author":"Small W.","year":"2017","unstructured":"Small W.; Bacon M.A.; Bajaj A.; Chuang L.T.; Fisher B.J.; Harkenrider M.M.; Jhingran A.; Kitchener H.C.; Mileshkin L.R.; Viswanathan A.N.; Gaffney D.K.; Cervical cancer: A global health crisis. Cancer 2017,123(13),2404-2412","journal-title":"Cancer"},{"key":"ref=5","author":"Wang Y.","year":"2020","unstructured":"Wang Y.; Master W. H.; Che S.; Master Y. Z.; Meng D.; Master F. S.; Master J. S.; Master Y. Y.; Ma H.; Liu R.; Outcomes for hyperthermia combined with concurrent radiochemotherapy for patients with cervical cancer. Int J Radiation Oncol Biol Phys 2020","journal-title":"Int J Radiation Oncol Biol Phys"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s40425-018-0458-z","volume":"6","author":"Raja J.","year":"2018","unstructured":"Raja J.; Ludwig J.M.; Gettinger S.N.; Schalper K.A.; Kim H.S.; Oncolytic virus immunotherapy: future prospects for oncology. J Immunother Cancer 2018,6(1),140","journal-title":"J Immunother Cancer"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2174\/156800907780058817","volume":"7","author":"Yu W.","year":"2007","unstructured":"Yu W.; Fang H.; Clinical trials with oncolytic adenovirus in China. Curr Cancer Drug Targets 2007,7(2),141-148","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.1128\/JVI.75.12.5443-5447.2001","volume":"75","author":"Dix B.R.","year":"2001","unstructured":"Dix B.R.; Edwards S.J.; Braithwaite A.W.; Does the antitumor adenovirus ONYX-015\/dl1520 selectively target cells defective in the p53 pathway? J Virol 2001,75(12),5443-5447","journal-title":"J Virol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1126\/science.272.5267.1470","volume":"272","author":"Dobner T.","year":"1996","unstructured":"Dobner T.; Horikoshi N.; Rubenwolf S.; Shenk T.; Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 1996,272(5267),1470-1473","journal-title":"Science"},{"key":"ref=10","year":"1996","unstructured":"Bischoff James, R.; Kirn.; David, H., An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 1996","journal-title":"Science"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1126\/science.2157286","volume":"248","author":"Werness B.A.","year":"1990","unstructured":"Werness B.A.; Levine A.J.; Howley P.M.; Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990,248(4951),76-79","journal-title":"Science"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/path.4991","volume":"244","author":"Leung T.H.","year":"2018","unstructured":"Leung T.H.; Tang H.W.; Siu M.K.; Chan D.W.; Chan K.K.; Cheung A.N.; Ngan H.Y.; Human papillomavirus E6 protein enriches the CD55(+) population in cervical cancer cells, promoting radioresistance and cancer aggressiveness. J Pathol 2018,244(2),151-163","journal-title":"J Pathol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"Crosbie E.J.","year":"2013","unstructured":"Crosbie E.J.; Einstein M.H.; Franceschi S.; Kitchener H.C.; Human papillomavirus and cervical cancer. Lancet 2013,382(9895),889-899","journal-title":"Lancet"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12885-015-1126-z","volume":"15","author":"Del R\u00edo-Ospina L.","year":"2015","unstructured":"Del R\u00edo-Ospina L.; Soto-De Le\u00f3n S.C.; Camargo M.; Moreno-P\u00e9rez D.A.; S\u00e1nchez R.; P\u00e9rez-Prados A.; Patarroyo M.E.; Patarroyo M.A.; The DNA load of six high-risk human papillomavirus types and its association with cervical lesions. BMC Cancer 2015,15,100","journal-title":"BMC Cancer"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.virol.2015.03.006","volume":"479","author":"Wiethoff C.M.","year":"2015","unstructured":"Wiethoff C.M.; Nemerow G.R.; Adenovirus membrane penetration: Tickling the tail of a sleeping dragon. Virology 2015,479(480),591-599","journal-title":"Virology"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1158\/1055-9965.EPI-19-0239","volume":"28","author":"Adcock R.","year":"2019","unstructured":"Adcock R.; Cuzick J.; Hunt W.C.; McDonald R.M.; Wheeler C.M.; Role of HPV genotype, multiple infections, and viral load on the risk of high-grade cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2019,28(11),1816-1824","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/sj.bjc.6602436","volume":"92","author":"Moberg M.","year":"2005","unstructured":"Moberg M.; Gustavsson I.; Wilander E.; Gyllensten U.; High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br J Cancer 2005,92(5),891-894","journal-title":"Br J Cancer"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2346::AID-CNCR14>3.0.CO;2-G","volume":"83","author":"Santin A.D.","year":"1998","unstructured":"Santin A.D.; Hermonat P.L.; Ravaggi A.; Chiriva-Internati M.; Pecorelli S.; Parham G.P.; Radiation-enhanced expression of E6\/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma. Cancer 1998,83(11),2346-2352","journal-title":"Cancer"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1096\/fj.00-0728fje","volume":"15","author":"Hampson L.","year":"2001","unstructured":"Hampson L.; El Hady E.S.; Moore J.V.; Kitchener H.; Hampson I.N.; The HPV16 E6 and E7 proteins and the radiation resistance of cervical carcinoma. FASEB J 2001,15(8),1445-1447","journal-title":"FASEB J"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.radonc.2015.02.005","volume":"114","author":"Hanna T.P.","year":"2015","unstructured":"Hanna T.P.; Shafiq J.; Delaney G.P.; Barton M.B.; The population benefit of radiotherapy for cervical cancer: local control and survival estimates for optimally utilized radiotherapy and chemoradiation. Radiother Oncol 2015,114(3),389-394","journal-title":"Radiother Oncol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10637-012-9870-2","volume":"31","author":"Milrot E.","year":"2013","unstructured":"Milrot E.; Jackman A.; Flescher E.; Gonen P.; Kelson I.; Keisari Y.; Sherman L.; Enhanced killing of cervical cancer cells by combinations of methyl jasmonate with cisplatin, X or alpha radiation. Invest New Drugs 2013,31(2),333-344","journal-title":"Invest New Drugs"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1038\/sj.onc.1206677","volume":"22","author":"Fei P.","year":"2003","unstructured":"Fei P.; El-Deiry W.S.; P53 and radiation responses. Oncogene 2003,22(37),5774-5783","journal-title":"Oncogene"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1073\/pnas.88.13.5523","volume":"88","author":"Scheffner M.","year":"1991","unstructured":"Scheffner M.; M\u00fcnger K.; Byrne J.C.; Howley P.M.; The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 1991,88(13),5523-5527","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.3390\/v7112905","volume":"7","author":"Cheng P-H.","year":"2015","unstructured":"Cheng P-H.; Wechman S.L.; McMasters K.M.; Zhou H.S.; Oncolytic replication of e1b-deleted adenoviruses. Viruses 2015,7(11),5767-5779","journal-title":"Viruses"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/jnci\/djj111","volume":"98","author":"Garber K.","year":"2006","unstructured":"Garber K.; China approves world\u2019s first oncolytic virus therapy for cancer treatment. J Natl Cancer Inst 2006,98(5),298-300","journal-title":"J Natl Cancer Inst"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/1568009618666171129221503","volume":"18","author":"Liang M.","year":"2018","unstructured":"Liang M.; Oncorine, the World first oncolytic virus medicine and its update in China. Curr Cancer Drug Targets 2018,18(2),171-176","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.3748\/wjg.v17.i18.2353","volume":"17","author":"He Q.","year":"2011","unstructured":"He Q.; Liu Y.; Zou Q.; Guan Y-S.; Transarterial injection of H101 in combination with chemoembolization overcomes recurrent hepatocellular carcinoma. World J Gastroenterol 2011,17(18),2353-2355","journal-title":"World J Gastroenterol"},{"key":"ref=28","first-page":"5031","volume":"60","author":"Okegawa T.","year":"2000","unstructured":"Okegawa T.; Li Y.; Pong R.C.; Bergelson J.M.; Zhou J.; Hsieh J.T.; The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. Cancer Res 2000,60(18),5031-5036","journal-title":"Cancer Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ijc.20217","volume":"111","author":"Bauerschmitz G.J.","year":"2004","unstructured":"Bauerschmitz G.J.; Kanerva A.; Wang M.; Herrmann I.; Shaw D.R.; Strong T.V.; Desmond R.; Rein D.T.; Dall P.; Curiel D.T.; Hemminki A.; Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer. Int J Cancer 2004,111(2),303-309","journal-title":"Int J Cancer"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-10-2333","volume":"70","author":"Kuroda S.","year":"2010","unstructured":"Kuroda S.; Fujiwara T.; Shirakawa Y.; Yamasaki Y.; Yano S.; Uno F.; Tazawa H.; Hashimoto Y.; Watanabe Y.; Noma K.; Urata Y.; Kagawa S.; Fujiwara T.; Telomerase-dependent oncolytic adenovirus sensitizes human cancer cells to ionizing radiation via inhibition of DNA repair machinery. Cancer Res 2010,70(22),9339-9348","journal-title":"Cancer Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1128\/JVI.71.5.3788-3798.1997","volume":"71","author":"Querido E.","year":"1997","unstructured":"Querido E.; Marcellus R.C.; Lai A.; Charbonneau R.; Teodoro J.G.; Ketner G.; Branton P.E.; Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J Virol 1997,71(5),3788-3798","journal-title":"J Virol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/15384047.2017.1294287","volume":"18","author":"Li X.","year":"2017","unstructured":"Li X.; Yuan L.; Zhao J.; Yang H.; Yang Y.; Zhang Y.; Cun B.; Adenovirus-based strategies enhance antitumor capability through p53-mediated downregulation of MGMT in uveal melanoma. Cancer Biol Ther 2017,18(3),194-199","journal-title":"Cancer Biol Ther"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/ajcp\/aqz186","volume":"153","author":"Cao M.","year":"2020","unstructured":"Cao M.; Wang Y.; Wang D.; Duan Y.; Hong W.; Zhang N.; Shah W.; Wang Y.; Chen H.; Increased high-risk human papillomavirus viral load Is associated With immunosuppressed microenvironment and predicts a worse long-term survival in cervical cancer patients. Am J Clin Pathol 2020,153(4),502-512","journal-title":"Am J Clin Pathol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejca.2016.06.006","volume":"65","author":"Qian G.","year":"2016","unstructured":"Qian G.; Wang D.; Magliocca K.R.; Hu Z.; Nannapaneni S.; Kim S.; Chen Z.; Sun S-Y.; Shin D.M.; Saba N.F.; Chen Z.G.; Human papillomavirus oncoprotein E6 upregulates c-Met through p53 downregulation. Eur J Cancer 2016,65,21-32","journal-title":"Eur J Cancer"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1242\/jcs.00739","volume":"116","author":"Haupt S.","year":"2003","unstructured":"Haupt S.; Berger M.; Goldberg Z.; Haupt Y.; Apoptosis - the p53 network. J Cell Sci 2003,116(Pt 20),4077-4085","journal-title":"J Cell Sci"}],"container-title":["Current Cancer Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/192103","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/192103\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/192103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T06:37:51Z","timestamp":1648449471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/192103\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568009621666210308103541","relation":{},"ISSN":["1568-0096"],"issn-type":[{"value":"1568-0096","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-09-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}